Homology Medicines, Inc.
Annual report (10-K)
Latest 10-K filed Mar 10, 2026. Sentiment + YoY language diff vs prior year. Read sections →
Sentiment via Loughran-McDonald lexicon · YoY diff via Jaccard similarity + paragraph set difference.
Recent 8-K announcements
Per-item disclosure feed. Item 2.02 is the earnings release.
Top insiders
Most active reporters at Homology Medicines, Inc.
| Name | Roles | Filings |
|---|---|---|
| Tzianabos Arthur | OfficerDirector | 10 |
| Alloway Paul | Officer | 9 |
| Seymour Albert | OfficerDirector | 8 |
| Violette Shelia M. | Officer | 7 |
| Kalowski Lee | Officer | 6 |
Showing 1-5 of 29
Top performers
Insiders ranked by realized 90-day signed return on their open-market trades at Homology Medicines, Inc.. Minimum 3 scored trades. Returns are signed - a sale followed by a rally counts against the insider.
| # | Insider | Trades | Win rate | Avg | Median | Best | Worst |
|---|---|---|---|---|---|---|---|
| 1 | Kalowski Lee | 3 | 0% | -35.7% | -45.2% | -12.1% | -49.9% |
| 2 | Morrison Jodie Pope | 3 | 0% | -35.7% | -45.2% | -12.1% | -49.9% |
All filings
107 Form 4 / 4-A filings, newest first
| Filed | Top transaction | Shares | Price | Value | ||
|---|---|---|---|---|---|---|